EE314 A Cost-Utility Analysis in Patients With Inflammatory Bowel Disease and Iron Deficiency Anemia in the Netherlands: Reduced Hypophosphatemia and Fracture Incidence With Ferric Derisomaltose Versus Ferric Carboxymaltose
Abstract
Authors
U Oron G Koek R Fijn R Pollock